Home
This site is intended for healthcare professionals

Obstructive Sleep Apnea Care Pathways Translating Cardiometabolic Risk into Longitudinal Management: Module 3 Clinical Risk Identification

Share

Description

This activity is supported by an independent education grant from Lilly. This online education program has been designed for healthcare professionals in the U.S.

Join Dr. Douglas Kirsch to learn how to recognize non-classic presentations of OSA that frequently lead to missed diagnoses, particularly in women or patients with a normal body mass index (BMI). This session focuses on identifying subtle clinical red flags—such as insomnia, unrefreshing sleep, nocturia, and morning headaches—and understanding when these symptoms warrant immediate screening due to underlying cardiometabolic risks.

Session Highlights

  • Recognize non-classic OSA presentations and red flags—such as morning headaches, insomnia, unrefreshing sleep, and persistent fatigue—to avoid missing diagnoses in patients lacking classic symptoms like loud snoring.
  • Address diagnostic disparities by acknowledging atypical symptom profiles, particularly in women or patients with normal body mass indexes (BMIs) who present with high-risk cardiometabolic comorbidity clusters.

Prefer to watch in Spanish? Click Here.

Who Should Participate?

This program is designed for healthcare professionals who seek to incorporate structured OSA screening and diagnostic activation into routine cardiometabolic management workflows.

  • Primary Care Physicians and Family Medicine Practitioners
  • Nurse Practitioners
  • Physician Assistants

This is Module Three of Six, See Modules 1, 2, 4 5 and 6 Here.

Prefer to read? See our Key Clinical Summary Here.

Faculty

Dr Douglas Kirsch

Dr Douglas Kirsch is Medical Director of Sleep Medicine at Atrium Health and a Professor of Internal Medicine and Neurology. A board-certified sleep medicine specialist, he has extensive expertise in the diagnosis and management of sleep disorders, with a particular research focus on obstructive sleep apnea. His research examines the impact of OSA treatment on patient hospitalizations and explores the use of consumer wearable devices to assess sleep in the home setting. Dr Kirsch is a former President of the American Academy of Sleep Medicine and is dedicated to improving sleep health and patient well-being.

Disclosures

Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships are mitigated according to Partners policies.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.

Dr Douglas Kirsch, faculty for this educational activity, has the following relevant financial relationships: Scientific Advisory Board Apnimed, Incannex, Huxley Medical. Expert Panel Carelon. Consulting ResMed.

The MedAll staff, program planners, and reviewers have no relevant financial relationships with ineligible companies to disclose.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and MedAll. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education

Partners designates this live activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Associate Continuing Education

Partners has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.25 ANCC contact hours.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Fee Information

There is no fee for this educational activity.

This continuing education activity is active starting September 11th 2026, and will expire on July 1st 2028.

Learning objectives

1: Evaluate the bidirectional relationship between obesity and OSA to inform cardiometabolic risk assessment, demonstrating accurate identification of OSA risk within ≥75% of post-activity case-based assessments.

2: Identify patients at increased risk of OSA using clinical features and comorbidities in primary care, achieving appropriate risk stratification in ≥75% of applied clinical scenarios.

3: Apply workflow-compatible screening and triage strategies to support early identification of OSA, demonstrating correct use of structured tools and decision pathways in ≥75% of simulation-based exercises.

4: Select appropriate diagnostic and referral pathways, including HSAT, based on clinical presentation and practice context, achieving appropriate pathway activation in ≥75% of case-based assessments.

5: Apply longitudinal management and treatment progression strategies in OSA care planning to support sustained disease control, demonstrating appropriate decision-making in ≥70% of longitudinal case exercises.

6: Apply contextually adapted care strategies that account for socioeconomic and practice-setting factors to support equitable diagnostic and management decisions in OSA, demonstrating appropriate decision-making in ≥70% of applied scenarios.

Similar communities

View all

Similar events and on demand videos

Computer generated transcript

Warning!
The following transcript was generated automatically from the content and has not been checked or corrected manually.

This section is focused on clinical risk identification. I'm Doug Kirsch. I'm a medical director of sleep medicine for Atrium Health and a professor at the Wake Forest School of Medicine. When talking about patients who have obstructive sleep apnea, there are classical features, things that we think of many patients having. People who snore, people whose bed partners report that they have witnessed apneas. Waking up choking and gasping at nighttime. And daytime sleepiness. Often this is correlated with obesity as a clinical finding, and sometimes, though not always, Retronaphia or large tongue size could also be a finding of relevance. However, patients don't always follow a textbook and you may not always find that all this information is available to you. Some of that time, that may be because patients don't tell it to you unless you ask specifically. Some of the time if patients are alone, sleeping alone in their own bed, uh, whether they have a spouse or not, You won't necessarily get the information about snoring or pauses in breathing. Some patients will say, hey, everybody snores. It's not a big deal. They don't necessarily think it's a problem. And sometimes patients won't connect the fact that they stop breathing or gasp at nighttime to a medical problem like sleep apnea. So just because you don't necessarily hear these classical signs or symptoms doesn't necessarily mean you shouldn't pursue the idea or think around. The fact that this patient might have obstructive sleep apnea, particularly in a patient who's at higher risk. These are some symptoms that you should think about that are not necessarily the most classical. So morning headaches. Getting up to go to the bathroom frequently at nighttime. Feeling fatigued or brain fog during the daytime. Having difficulty sleeping at nighttime. Having difficulty remembering things or difficulty concentrating. And symptoms of depression or other mood disturbance. Recognize that sleep disturbance of various types can be related to these symptoms as well. And so just because they might not have some of those classic symptoms that we discussed in the previous slide doesn't mean you shouldn't consider these symptoms as well. Recognized particularly in patients who are at high risk for sleep apnea, so those who are obese, those who have hypertension, those with type 2 diabetes, or those with high cardiovascular risk or things like arrhythmias, atrial fibrillation, and the like. So recognize just because you don't have the classic symptoms doesn't mean you shouldn't ask about some of these non-classical symptoms. So I mentioned this on the previous slide, but I think it's important to reiterate that certain disease classes correlate with sleep apnea. What are those diseases? Things like patients who have resistant hypertension, where one medication just isn't fixing the problem when they need 3 or 4, or type 2 diabetes, often related to obesity. Those two correlate together but not always. Those with heart failure or cardiovascular disease. People who've had recent heart attacks, people who have recent arrhythmias or atrial fibrillation. All of these patients are at theoretically higher risk for having sleep apnea just by the nature of those diseases. We know that obstructive sleep apnea is more likely to cause resistant hypertension. We know that it is more likely to occur in obesity. We know that in patients who have atrial fibrillation, having obstructive sleep apnea correlates with a difficulty in getting that atrial fibrillation under control. So if you combine some of these non-classical symptoms that we discussed, fatigue, trips to the bathroom at nighttime, nocturia, morning headache, brain fog, poor sleep quality, that also should trigger in the back of your mind, hey, Do I need to worry about sleep apnea in this particular patient population? Should I be thinking about taking that a step further and considering whether this patient needs to be tested? So recognize the threshold for assessing patients in this group is maybe perhaps a little lower, even if they're not telling you, hey, I'm snoring really badly, or, hey, I stopped breathing regularly. So let's stop for a polling question here. Which non-classic red flag are you least confident recognizing in your own patients? A, morning headache, B, nocturia, C, treatment resistant depression or anxiety. And the unexplained fatigue. I'll pause here for a moment to let you answer those polling, uh, answer this polling question. So Where should you be looking for OSA? What patients might be, where you should give it a little extra thought. So for instance, when you see a patient back and follow up for their diabetes, maybe you consider asking about fatigue or morning headache or trips to the bathroom at nighttime. Why does it matter? Well, we know that patients who have untreated sleep apnea may have less well controlled diabetes. It's also very common in that population and so again trying to deal with helping getting control of the problem that the patient is focusing on that control of their sugars. In a hypertension visit, particularly if it's resistant, you're having difficulty getting it under control, it's requiring multiple medications. Thinking about asking about sleep quality and snoring and apneas. Daytime sleepiness, all these things, classical symptoms to consider asking about in a patient who you think. Might be at risk for sleep apnea. In those with heart conditions, atrial fibrillation, cardiovascular disease, again, snoring, choking, gasping, fatigue, sleep disruption. As I mentioned previously, we know that sleep apnea and atrial fibrillation are highly correlated. But it's also correlated sleep apnea with heart failure and stroke and other cardiovascular complications. And so it's important in this population particularly to ask for at least some of the classical symptoms around sleep apnea. In patients where you are checking on their mental health or they are feeling very fatigued, certainly asking about insomnia symptoms or unrefreshing sleep or brain fog, these symptoms are very common. They are not necessarily specific for sleep apnea, but they could be correlated with sleep apnea. And again raises the idea of whether this is something that is worth chasing in that particular patient, recognizing that sleep apnea may present not just as sleepiness but as fatigue, poor concentration, or mood symptoms. And then lastly, in an annual wellness visit. Asking at least one question about either snoring or daytime sleepiness when you have a patient who is obese or has cardio metabolic disease, it may be worth just that one question in that long visit to sort of make sure that you've covered that particular base. Um, and screening them helps you make sure you haven't missed this chronic important medical condition. Women are a specific group that bear attention, and it's because they don't always present with classical symptoms for obstructive sleep apnea. They tend to be missed or underdiagnosed compared to the men of similar weight and ages. And just because somebody reports that they don't snore or don't have apnea doesn't mean that it's not worth considering assessment of sleep apnea in this large population of a medical practice. Recognize that women are less likely to present with the classical snoring, gasping at nighttime and with the classical, Hey, I fall asleep during the daytime when I shouldn't. They are more likely than the similar men of age and weight to present with difficulty sleeping at nighttime, being more depressed, having morning headaches, having nightmares during sleep. And being fatigued during the daytime. Recognize that. Women will tell a different story than that of men, and it's important not to miss that when they are telling you about some of the symptoms they have, particularly in people who are at risk based on their cardio metabolic disease. So if they have diabetes, if they are